AZN vs SBDS · P/E 28, $288.38B cap vs rev $151.3M
AstraZeneca PLC (AZN) versus Solo Brands, Inc. (SBDS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Solo Brands, Inc. (SBDS) is a internet retail company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported SBDS revenue for 2026-06-30 was $151.3M. Net income was -$9.9M. SBDS currently screens at market cap $10.0M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SBDS currently screens at market cap $10.0M.
Not investment advice. Open the AZN and SBDS stock pages for the full models.
Not investment advice.